April 2018 newsletter
Updates on impact investment, collaboration with Malta and more
Our April 2018 newsletter is online. Find it here.
In this newsletter we highlight:
- Updates on our endeavors in impact investing in life sciences
- Start of a collaboration with Malta to redesign market access evaluations
- Enrollment in our epilepsy seizure dog trial
- Closing of the prostate cancer registry